TickerKhojComparison · NSE · data 2026-11-02
Morepen Laboratories Limited vs Sun Pharma Advanced Research Co. Ltd.
In plain words
Size: Morepen Laboratories Limited is about 1.1 times the market value of Sun Pharma Advanced Research Co. Ltd..
Valuation (P/E): Morepen Laboratories Limited 31.3 vs Sun Pharma Advanced Research Co. Ltd. 3.6.
Return on equity: Sun Pharma Advanced Research Co. Ltd. 276.9% vs Morepen Laboratories Limited 7.9%.
Debt to equity: Sun Pharma Advanced Research Co. Ltd. 0.42 vs Morepen Laboratories Limited 0.17.
Differences in the numbers, not a recommendation of either stock.
Side by side
| MOREPENLAB | SPARC | |
|---|---|---|
| Price | ₹107.69 | ₹176.05 |
| Market cap | ₹6,230 cr | ₹5,741 cr |
| P/E | 31.3 | 3.6 |
| P/B | 4.3 | — |
| ROE | 7.9% | 276.9% |
| ROCE | 6.2% | 232.1% |
| Debt / equity | 0.17 | 0.42 |
| Operating margin | 10.6% | 84.2% |
| Dividend yield | 0.18% | 0.00% |
| Sales growth, 3 years (yearly) | 8.4% | 98.9% |
| Profit growth, 3 years (yearly) | 34.9% | — |
| 1-year return | 123.1% | 29.4% |
| Revenue, last 12 months | ₹2,286 cr | ₹1,909 cr |
| Net profit, last 12 months | ₹189 cr | ₹1,584 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹89 cr | ₹-24 cr |
| Quarter profit vs a year earlier | +117.5% | — |
| Promoter holding | 35.65% | 65.67% |
| Health check | Strong (7.2/10) | Strong (8.7/10) |
Common questions
Which has a higher P/E, Morepen Laboratories Limited or Sun Pharma Advanced Research Co. Ltd.?
Morepen Laboratories Limited trades at the higher P/E (31.3 against 3.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Sun Pharma Advanced Research Co. Ltd. (276.9% against 7.9%).
Which carries more debt?
Sun Pharma Advanced Research Co. Ltd. has the higher debt-to-equity ratio (0.42 against 0.17).